A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 51/00 (2006.01) A61K 38/00 (2006.01) A61K 38/16 (2006.01) A61K 47/48 (2006.01) C07K 17/00 (2006.01) C08H 1/00 (2006.01)
Patent
CA 2414401
This invention relates to the targeted delivery of cytotoxic drugs: A) to lymphocytes responsible for the rejection of transplanted tissues, such as kidneys or hearts or bone marrow cells; B) the use of a non-toxic naturally existing delivery system to transport high concentrations of radiosensitizers to cancer cells; and C) to the targeted delivery of drugs in medical diagnosis and treatment of cancer.
L'invention concerne la diffusion ciblée de médicaments cytotoxiques : A) à des lymphocytes responsables du rejet de tissus transplantés, comme des reins, des coeurs ou des cellules de moelle osseuse. B) L'invention concerne l'utilisation d'un système non-toxique de diffusion existant naturellement afin de transporter de fortes concentrations de radiosensibiliseurs des cellules cancéreuses. C) L'invention concerne également la diffusion ciblée de médicaments en cas de diagnostic médical et de traitement du cancer.
Faulk Ward Page
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Faulk Ward Page
LandOfFree
Targeted delivery of cytotoxic drugs a) to activated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Targeted delivery of cytotoxic drugs a) to activated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Targeted delivery of cytotoxic drugs a) to activated... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1746436